Cancer multidrug resistance

被引：0
|
作者：
Aris Persidis
机构：
[1] Aris Persidis is vice president for business development at Argonex Inc.,
来源：
Nature Biotechnology | 1999年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：94 / 95
页数：1
相关论文
共 50 条
  • [1] MULTIDRUG RESISTANCE IN CANCER
    KARTNER, N
    LING, V
    SCIENTIFIC AMERICAN, 1989, 260 (03) : 44 - 51
  • [2] Cancer multidrug resistance
    不详
    Nature Biotechnology, 2000, 18 (Suppl 10) : IT18 - IT20
  • [3] Cancer multidrug resistance
    Persidis, A
    NATURE BIOTECHNOLOGY, 1999, 17 (01) : 94 - 95
  • [4] MULTIDRUG RESISTANCE IN CANCER
    不详
    LANCET, 1989, 2 (8671): : 1075 - 1076
  • [5] MULTIDRUG RESISTANCE IN HUMAN CANCER
    GOLDSTEIN, LJ
    PASTAN, I
    GOTTESMAN, MM
    CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1992, 12 (03) : 243 - 253
  • [6] Targeting multidrug resistance in cancer
    Szakács, G
    Paterson, JK
    Ludwig, JA
    Booth-Genthe, C
    Gottesman, MM
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (03) : 219 - 234
  • [7] Autophagy and multidrug resistance in cancer
    YingJie Li
    YuHe Lei
    Nan Yao
    ChenRan Wang
    Nan Hu
    WenCai Ye
    DongMei Zhang
    ZheSheng Chen
    ChineseJournalofCancer, 2017, 36 (08) : 342 - 351
  • [8] Autophagy and multidrug resistance in cancer
    Li, Ying-Jie
    Lei, Yu-He
    Yao, Nan
    Wang, Chen-Ran
    Hu, Nan
    Ye, Wen-Cai
    Zhang, Dong-Mei
    Chen, Zhe-Sheng
    CHINESE JOURNAL OF CANCER, 2017, 52 : 52
  • [9] Multidrug resistance in prostate cancer
    van Brussel, JR
    Mickisch, GHJ
    ONKOLOGIE, 2003, 26 (02): : 175 - 181
  • [10] Imaging of multidrug resistance in cancer
    Dizdarevic, S.
    Peters, A. M.
    CANCER IMAGING, 2011, 11 (01): : 1 - 8
12345